Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Central Nervous System Neoplasms 2Radiation Injuries 1Radiation Fibrosis Syndrome 1Postoperative Complications 1Lymphedema 1Laryngeal Neoplasms 1Gliosarcoma 1Glioblastoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 10Specimen Handling 9Radiotherapy 8Cisplatin 7Paclitaxel 4Cetuximab 4Biopsy 4pembrolizumab 3Platinum 31,2-diaminocyclohexaneplatinum II citrate 3(225)Ac-DOTA-c(RGDyK) 3ipatasertib 2cemiplimab 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Radiation 2Immunoglobulin G 2Gemcitabine 2Fluorouracil 2Fluorodeoxyglucose F18 2Disulfides 2Carboplatin 2sargramostim 1peposertib 1fluoromisonidazole 1durvalumab 1dl1520 1cabozantinib 1atezolizumab 1Transurethral Resection of Bladder 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Laryngeal Neoplasms × Hyperbaric Oxygenation × Clear all
NCT00026975 2006-08-18

Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients

National Center for Complementary and Integrative Health (NCCIH)

Phase 2 Completed
150 enrolled
Head & Neck

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡